Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls-Reference-Cited by-同舟云学术

Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls

Published:1995-11 Issue:2 Volume:62 Page:177-181
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Munschauer F.E.,Hartrich L.A.,Stewart C.C.,Jacobs L.

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference14 articles.

1. Human leukocyte IgG Fc receptors;Anderson;Immunol. Today,1986

2. A pilot trial of COP 1 in exacerbating-remitting multiple sclerosis;Bornstein;New Engl. J. Med.,1987

3. Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-2. Clin;Hirsch;Immunol. Immunopathol.,1985

4. Natural killer (NK) cells in chronic progressive multiple sclerosis patients treated with lymphoblastoid interferon;Kastrukoff;J. Neuroimmunol.,1988

5. Enumeration of T, B and natural killer peripheral blood cells of patients with multiple sclerosis and controls;Kreuzfelder;Eur. Neurol.,1992

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Immune Response in Multiple Sclerosis;Annual Review of Pathology: Mechanisms of Disease;2022-01-24

2. Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study;CNS Drugs;2021-12-11

3. Fingolimod Therapy in Multiple Sclerosis Leads to the Enrichment of a Subpopulation of Aged NK Cells;Neurotherapeutics;2021-07

4. Classification of neurological diseases using multi-dimensional CSF analysis;Brain;2021-04-13

5. Imbalance of T Lymphocyte Subsets in Adult Immune Thrombocytopenia;International Journal of General Medicine;2021-03